• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.

作者信息

Trecarichi Enrico Maria, Quirino Angela, Scaglione Vincenzo, Longhini Federico, Garofalo Eugenio, Bruni Andrea, Biamonte Eugenio, Lionello Rosaria, Serapide Francesca, Mazzitelli Maria, Marascio Nadia, Matera Giovanni, Liberto Maria Carla, Navalesi Paolo, Torti Carlo

机构信息

Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, 'Magna Graecia' University, Catanzaro, Italy.

Unit of Clinical Microbiology, Department of Health Sciences, 'Magna Graecia' University, Catanzaro, Italy.

出版信息

J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401. doi: 10.1093/jac/dkz318.

DOI:10.1093/jac/dkz318
PMID:31369095
Abstract
摘要

相似文献

1
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.头孢地尔在一名患有广泛耐药鲍曼不动杆菌和产KPC肺炎克雷伯菌的重症患者中同情用药的成功治疗：一例报告
J Antimicrob Chemother. 2019 Nov 1;74(11):3399-3401. doi: 10.1093/jac/dkz318.
2
Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.仅在罗马尼亚一家心脏重症监护病房出现对黏菌素耐药的产超广谱β-内酰胺酶（ESBL）阳性肺炎克雷伯菌与仅对黏菌素敏感的产OXA-23型鲍曼不动杆菌的合并感染。
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2069-74. doi: 10.1007/s10096-015-2453-3. Epub 2015 Aug 4.
3
Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.在全身性败血症感染小鼠模型中，杀鱼菌素对耐碳青霉烯类鲍曼不动杆菌和产NDM-1的肺炎克雷伯菌具有高度活性。
Mar Drugs. 2015 Apr 14;13(4):2287-305. doi: 10.3390/md13042287.
4
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.头孢地尔在复制人体血浆药代动力学的免疫功能正常大鼠呼吸道感染模型中对碳青霉烯类耐药革兰氏阴性杆菌的疗效。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00700-17. Print 2017 Sep.
5
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.沙特阿拉伯朱夫地区血流感染的病原菌谱和革兰氏阴性菌的耐药模式。
PLoS One. 2020 Jun 9;15(6):e0233704. doi: 10.1371/journal.pone.0233704. eCollection 2020.
6
Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.耐碳青霉烯类肺炎克雷伯菌和多重耐药鲍曼不动杆菌血流感染：一例报告
Chin Med Sci J. 2014 Mar;29(1):51-4. doi: 10.1016/s1001-9294(14)60025-0.
7
Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.替加环素用于耐多药（MDR）肺炎克雷伯菌或耐多药鲍曼不动杆菌所致泌尿系统感染的药代动力学考量
J Clin Microbiol. 2009 May;47(5):1613. doi: 10.1128/JCM.00404-09.
8
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.多重耐药感染与 2019 年冠状病毒病危重症患者的结局：单中心经验。
Microb Drug Resist. 2021 Sep;27(9):1167-1175. doi: 10.1089/mdr.2020.0489. Epub 2021 Feb 17.
9
Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.头孢地尔长期同情用药治疗一名儿科患者由广泛耐药铜绿假单胞菌和产超广谱β-内酰胺酶肺炎克雷伯菌引起的慢性骨髓炎
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01872-19.
10
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii.头孢地尔在治疗广泛和泛耐药鲍曼不动杆菌引起的复杂感染中的同情用药。
J Glob Antimicrob Resist. 2020 Dec;23:292-296. doi: 10.1016/j.jgar.2020.09.019. Epub 2020 Oct 13.

引用本文的文献

1
Carbapenem-Resistant spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.治疗选择有限的重症患者中的耐碳青霉烯类菌感染：COVID-19大流行期间头孢地尔治疗的描述性研究
Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul.
2
Activity of Cefiderocol Against Carbapenem-Resistant Clinical Isolates: a Single Center Experience.头孢地尔对耐碳青霉烯临床分离株的活性：单中心经验
Mediterr J Hematol Infect Dis. 2023 Jul 1;15(1):e2023043. doi: 10.4084/MJHID.2023.043. eCollection 2023.
3
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.
用头孢地尔治疗重症患者耐多药病原体引起的感染：证据综述
Ann Intensive Care. 2023 Jun 15;13(1):52. doi: 10.1186/s13613-023-01146-5.
4
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic.基于头孢地尔与基于黏菌素的方案治疗严重碳青霉烯耐药感染：COVID-19大流行头两年的倾向评分加权回顾性队列研究
Microorganisms. 2023 Apr 10;11(4):984. doi: 10.3390/microorganisms11040984.
5
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales.头孢地尔，一种铁载体头孢菌素，作为耐碳青霉烯类肠杆菌科细菌所致感染的一种治疗选择。
Infect Dis Ther. 2023 Mar;12(3):777-806. doi: 10.1007/s40121-023-00773-6. Epub 2023 Feb 25.
6
The Role of Novel Antibiotics in the Management of Diabetic Foot Infection.新型抗生素在糖尿病足感染治疗中的作用
Diabetes Ther. 2023 Feb;14(2):251-263. doi: 10.1007/s13300-022-01357-2. Epub 2022 Dec 24.
7
Successful Treatment of Aortic Endocarditis by with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review.非霍奇金淋巴瘤患者采用头孢地尔联合疗法成功治疗主动脉心内膜炎：病例报告及文献综述
Antibiotics (Basel). 2022 Nov 23;11(12):1686. doi: 10.3390/antibiotics11121686.
8
The role of cefiderocol in clinical practice.头孢地尔在临床实践中的作用。
Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):39-44. doi: 10.37201/req/s02.06.2022. Epub 2022 Oct 4.
9
Clinical experience of cefiderocol.头孢地尔科尔的临床经验。
Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):35-38. doi: 10.37201/req/s02.05.2022. Epub 2022 Oct 4.
10
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.革兰氏阴性杆菌对β-内酰胺类抗生素的耐药性：相关性和潜在的治疗替代方案。
Rev Esp Quimioter. 2022 Sep;35 Suppl 2(Suppl 2):1-15. doi: 10.37201/req/s02.01.2022. Epub 2022 Oct 4.